September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
Proteomics on the route towards molecular mechanisms, risk factors, and biomarkers of glaucoma
Author Affiliations & Notes
  • Gulgun Tezel
    Ophthalmology, Columbia University, New York, New York, United States
  • Footnotes
    Commercial Relationships   Gulgun Tezel, None
  • Footnotes
    Support  NIH Grant 1R21EY024105, GRF, and RPB
Investigative Ophthalmology & Visual Science September 2016, Vol.57, No Pagination Specified. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Gulgun Tezel; Proteomics on the route towards molecular mechanisms, risk factors, and biomarkers of glaucoma. Invest. Ophthalmol. Vis. Sci. 201657(12):.

      Download citation file:


      © 2017 Association for Research in Vision and Ophthalmology.

      ×
  • Supplements
Abstract

Presentation Description : This presentation will provide an overview of the recent applications of proteomics analysis techniques in the field of glaucoma research and will highlight valuable implications in translational and clinical research towards better understanding and treatment of glaucomatous neurodegeneration.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×